Hepatitis C: the lurking dragon

Area of Science:

• Hepatology
• Infectious Diseases
• Public Health

Background:

• Hepatitis C virus (HCV) is the most prevalent chronic blood-borne infection in the U.S.
• Chronic liver disease (CLD) is a leading cause of death, with HCV accounting for a substantial portion.
• HCV/HIV coinfection is common and exacerbates HIV disease progression.

Purpose of the Study:

• To highlight the significant public health burden of Hepatitis C virus infection in the United States.
• To underscore the contribution of HCV to chronic liver disease mortality.
• To emphasize the impact of HCV/HIV coinfection on disease progression.

Main Methods:

• Epidemiological data analysis on HCV prevalence.
• Review of mortality statistics for chronic liver disease.
• Assessment of HCV coinfection rates in HIV-positive populations.

Main Results:

• An estimated 3.9 million Americans are infected with HCV (1.4% of the population).
• HCV accounts for approximately 40% of all CLD cases, causing 8,000-10,000 deaths annually.
• An estimated 60% of individuals with HIV are coinfected with HCV.

Conclusions:

• Hepatitis C virus represents a major public health challenge in the U.S. due to its high prevalence and association with CLD mortality.
• The high rate of HCV/HIV coinfection necessitates integrated care strategies to manage both infections and prevent accelerated disease progression.